Based on recent headline ratings, 71% of this readership currently trusts the local media, which has an average score of 85% regionally and is currently trending negative.
Media Trust Score71%

AbbVie Announces Late-Breaking Results from Phase 2 Exploratory NOVA Trial of Novel …

Primary endpoint was not met for the modified intent-to-treat (mITT) population; however, clinical benefit observed in coronary artery bypass …

  • You already voted!
  • Read More